Signal-Transducing Adaptor Proteins in Periodontal Disease
Investigation of the Role of Signal-Transducing Adaptor Proteins in Periodontal Disease
1 other identifier
observational
75
1 country
1
Brief Summary
This study will look at certain proteins in the gums, saliva, and gum fluid of people with healthy gums, gingivitis (mild gum inflammation), or periodontitis (more severe gum disease). The proteins to be studied called STAP-1, STAP-2, STAT3, STAT5A, NLRP3, and CASP3, are known to be involved in inflammation and cell health in other diseases, but their role in gum disease is not well understood. Seventy-five healthy adults will be grouped by their gum health status. Samples of saliva and gum fluid will be collected and tested, and gum tissue samples will be collected from a subset of participants during routine dental treatment. Researchers will measure the levels of these proteins and look for patterns linking them to the severity of gum disease. The results are expected to show whether these proteins are found at different levels in people with periodontitis compared to those with healthy gums, suggesting they may play a role in how gum disease develops and progresses. This information may help researchers better understand the biological processes behind periodontal disease and could eventually contribute to new ways of detecting or treating it.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedFirst Submitted
Initial submission to the registry
August 3, 2026
CompletedFirst Posted
Study publicly available on registry
August 7, 2026
CompletedAugust 7, 2026
August 1, 2026
7 months
August 3, 2026
August 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
GCF, saliva and Gingival levels of STAP-1, STAP-2, STAT3, STAT5A, NLRP3 and CASP3
Gene expression (RT-PCR, relative fold change via 2\^-ΔΔCT method)levels of STAP-1, STAP-2, STAT3, STAT5A, NLRP3 and CASP3 were measured in gingiva of participants. Protein levels of STAP-1, STAP-2, STAT3, STAT5A, NLRP3 and CASP3 in GCF and saliva were measured by ELISA in study participants.
From may to December 2024
Study Arms (3)
periodontally healthy
periodontally healthy participants
gingivitis
patients with gingivitis
periodontitis
patients with periodontitis
Eligibility Criteria
Adults aged 18 to 60 years attending the periodontology clinic were enrolled and classified into three groups based on clinical periodontal parameters according to the 2017 World Workshop classification: periodontal health, gingivitis, and periodontitis (Stage III). Exclusion criteria included any systemic disease, regular medication use, smoking, pregnancy or lactation, periodontal treatment within the past 6 months, antibiotic use within the past 6 months, and presence of prosthetic restorations on the teeth to be sampled. A total of 75 participants (25 per group; 38 male, 37 female) were included.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Inonu Universitylead
Study Sites (1)
Kubra Aral , Phd Ext. 422 341 01 06 kubra.aral@inonu.edu.tr
Malatya, 44100, Turkey (Türkiye)
Related Publications (4)
Aral K, Aral CA, Kapila Y. The role of caspase-8, caspase-9, and apoptosis inducing factor in periodontal disease. J Periodontol. 2019 Mar;90(3):288-294. doi: 10.1002/JPER.17-0716. Epub 2018 Oct 26.
PMID: 30311940BACKGROUNDAral K, Milward MR, Kapila Y, Berdeli A, Cooper PR. Inflammasomes and their regulation in periodontal disease: A review. J Periodontal Res. 2020 Aug;55(4):473-487. doi: 10.1111/jre.12733. Epub 2020 Jan 20.
PMID: 31960443BACKGROUNDLuo L, Wang F, Xu X, Ma M, Kuang G, Zhang Y, Wang D, Li W, Zhang N, Zhao K. STAT3 promotes NLRP3 inflammasome activation by mediating NLRP3 mitochondrial translocation. Exp Mol Med. 2024 Sep;56(9):1980-1990. doi: 10.1038/s12276-024-01298-9. Epub 2024 Sep 2.
PMID: 39218978BACKGROUNDKashiwakura JI, Oritani K, Matsuda T. The Functional Properties and Physiological Roles of Signal-Transducing Adaptor Protein-2 in the Pathogenesis of Inflammatory and Immune Disorders. Biomedicines. 2022 Nov 30;10(12):3079. doi: 10.3390/biomedicines10123079.
PMID: 36551835BACKGROUND
Biospecimen
Residual gingival crevicular fluid (GCF) samples will be retained as backup specimens in case repeat ELISA analysis is required due to technical issues (e.g., assay failure, insufficient sample volume, or inconclusive results). Retained samples will not be used for DNA extraction and will be stored at -80°C.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 3, 2026
First Posted
August 7, 2026
Study Start
May 1, 2024
Primary Completion
December 1, 2024
Study Completion
December 1, 2024
Last Updated
August 7, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Beginning 6 months and ending 24 months following article publication
- Access Criteria
- Data will be made available to researchers who provide a methodologically sound proposal, subject to approval by the corresponding author, for the purpose of achieving the aims outlined in the approved proposal.
De-identified individual participant data will be shared, including participant age, sex, and clinical periodontal parameters (plaque index, gingival index, probing depth, clinical attachment level, bleeding on probing). Participants will be identified only by coded/numbered case report forms; no names, gender identity beyond biological sex, or other identifying information will be shared.